Targeted SERCA2a gene expression identifies molecular mechanism and therapeutic target for arrhythmogenic cardiac

Michael J Cutler1, Xiaoping Wan, Kenneth R Laurita

  • 1The Heart and Vascular Research Center, MetroHealth Campus, Case Western Reserve University, Cleveland, OH 44109-1998, USA.

Abstract

Insights

Increasing sarcoplasmic reticulum calcium reuptake via SERCA2a gene expression significantly reduces cellular alternans and ventricular arrhythmias. This finding highlights SERCA2a

Area of Science:

  • Cardiology
  • Molecular Biology
  • Electrophysiology

Background:

  • Beat-to-beat alternans in cellular repolarization are strongly associated with human ventricular arrhythmias.
  • The role of sarcoplasmic reticulum calcium reuptake by SERCA2a in cellular alternans remains to be elucidated.

Purpose of the Study:

  • To investigate the central role of SERCA2a in the mechanism of cellular alternans.
  • To determine if enhanced SERCA2a gene expression can prevent the development of cellular alternans.

Main Methods:

  • In vivo gene transfer using an adenoviral vector (Ad.SERCA2a) in guinea pigs.
  • Assessment of sarcoplasmic reticulum Ca(2+) reuptake and cytosolic calcium alternans in isolated myocytes.
  • Evaluation of action potential duration alternans and arrhythmia susceptibility in intact hearts.

Main Results:

  • SERCA2a gene transfer improved sarcoplasmic reticulum Ca(2+) reuptake and conferred resistance to cytosolic calcium alternans.
  • Overexpression of SERCA2a in intact hearts increased the threshold for alternans development.
  • SERCA2a overexpression led to a significant 4-fold reduction in susceptibility to alternans-mediated ventricular arrhythmias.

Conclusions:

  • Sarcoplasmic reticulum Ca(2+) reuptake directly influences susceptibility to cellular alternans.
  • SERCA2a overexpression effectively suppresses cellular alternans, mitigating a key pathway to cardiac fibrillation.